August 14, 2023
A post hoc analysis of the landmark SOLOIST-WFH trial supports avoiding delay in initiating the SGLT-2/1 inhibitor as part of guideline-recommended treatment.
August 11, 2023
Antiobesity drug reduces CVD risk; postpartum depression Rx approved; sugary drinks up adverse hepatic events in older women; cuff size does matter, more.
August 10, 2023
Postmenopausal women who consumed 1 or more sugary drinks daily had a nearly 2-fold increased risk of liver cancer in a study of more than 98 000.
August 09, 2023
Most Americans are aware of the hot prescription drugs associated with weight loss and many are interested in using them. But access and administration are problematic.
August 08, 2023
The reduction in risk of CV events, the first to be shown by an antiobesity drug, was higher than expected and could help alter perceptions of the agents as "lifestyle drugs."
August 08, 2023
Blood pressure cuffs that are too large or too small for an individual's upper arm return measurements that may misguide therapeutic decisions, say study authors.
August 04, 2023
The oral gepant reduced monthly migraine days as well as mean monthly use of migraine rescue medication.
August 04, 2023
ACP CRC first screening age questioned; elders over age 75 years respond better to statins; 1 drink/day ups risk for HTN; OTC lifesaver #2; plus a triple virus assay.
August 03, 2023
The only head-to-head trial of mRNA COVID-19 vaccine safety in older adults finds one has a slight edge over the other, which might just be enough for some patients.
August 03, 2023
Statistically significant positive immune responses were observed in both vaccine-naive adults and those previously vaccinated, including for the vaccine's 8 unique serotypes.